A Phase I/II Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Status: Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 09 Sep 2019
Price : $35 *
At a glance
- Drugs Vosaroxin (Primary) ; Decitabine
- Indications Acute myeloid leukaemia; Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- 05 Sep 2019 Planned End Date changed from 1 Jul 2020 to 1 Dec 2020.
- 05 Sep 2019 Planned primary completion date changed from 1 Jul 2019 to 1 Dec 2019.
- 05 Feb 2018 Planned End Date changed from 1 Jul 2018 to 1 Jul 2020.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History